Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:BWAY NASDAQ:SNWV NASDAQ:TCMD NASDAQ:VANI On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBWAYBrainsway$15.23$14.54$7.84▼$17.00$288.96M1.2362,306 shs43,078 shsSNWVSanuwave Health$32.01-21.6%$37.78$5.63▼$46.58$349.75M1.3357,139 shs537,821 shsTCMDTactile Systems Technology$14.84-2.2%$13.10$8.61▼$21.10$338.17M1.04184,394 shs120,094 shsVANIVivani Medical$1.37-2.8%$1.32$0.91▼$1.80$83.53M3.18211,935 shs104,079 shs10 Best Stocks to Own: Fall 2025Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBWAYBrainsway-0.52%-0.39%-3.91%+18.34%+60.32%SNWVSanuwave Health+9.06%+17.98%+7.76%+17.00%+4,081,999,900.00%TCMDTactile Systems Technology-0.20%+9.69%+12.70%+52.00%+4.98%VANIVivani Medical+0.71%+0.71%+9.30%+11.02%+19.49%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBWAYBrainsway$15.23$14.54$7.84▼$17.00$288.96M1.2362,306 shs43,078 shsSNWVSanuwave Health$32.01-21.6%$37.78$5.63▼$46.58$349.75M1.3357,139 shs537,821 shsTCMDTactile Systems Technology$14.84-2.2%$13.10$8.61▼$21.10$338.17M1.04184,394 shs120,094 shsVANIVivani Medical$1.37-2.8%$1.32$0.91▼$1.80$83.53M3.18211,935 shs104,079 shs10 Best Stocks to Own: Fall 2025Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBWAYBrainsway-0.52%-0.39%-3.91%+18.34%+60.32%SNWVSanuwave Health+9.06%+17.98%+7.76%+17.00%+4,081,999,900.00%TCMDTactile Systems Technology-0.20%+9.69%+12.70%+52.00%+4.98%VANIVivani Medical+0.71%+0.71%+9.30%+11.02%+19.49%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBWAYBrainsway 2.67Moderate Buy$18.0018.19% UpsideSNWVSanuwave Health 2.75Moderate Buy$54.0068.70% UpsideTCMDTactile Systems Technology 2.43Hold$16.8313.43% UpsideVANIVivani Medical 2.00Hold$4.00191.97% UpsideCurrent Analyst Ratings BreakdownLatest VANI, TCMD, SNWV, and BWAY Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails10/7/2025SNWVSanuwave HealthRoth CapitalSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price TargetBuy$53.0010/3/2025TCMDTactile Systems TechnologyLake Street CapitalSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageBuy$23.509/27/2025BWAYBrainswayWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingHold (C-)9/27/2025SNWVSanuwave HealthWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)9/27/2025TCMDTactile Systems TechnologyWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingHold (C)9/27/2025VANIVivani MedicalWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)9/3/2025SNWVSanuwave HealthNorthland CapmkSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeStrong-Buy9/3/2025SNWVSanuwave HealthNorthland SecuritiesSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageOutperform$55.009/2/2025VANIVivani MedicalHC WainwrightSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$4.008/25/2025BWAYBrainswayHC WainwrightSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$17.008/22/2025SNWVSanuwave HealthRoth CapitalSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$54.00 ➝ $55.00(Data available from 10/7/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBWAYBrainsway$41.02M7.04$0.25 per share61.08$3.31 per share4.60SNWVSanuwave Health$32.63M8.41N/AN/A($1.49) per share-21.48TCMDTactile Systems Technology$292.98M1.13$1.06 per share14.02$9.03 per share1.64VANIVivani MedicalN/AN/AN/AN/A$0.30 per shareN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBWAYBrainsway$2.92M$0.2658.5895.19N/A11.60%8.97%5.65%11/11/2025 (Estimated)SNWVSanuwave Health-$31.37M-$8.25N/A∞N/A-97.03%N/A-135.15%N/ATCMDTactile Systems Technology$16.96M$0.6223.9417.67N/A5.06%7.72%5.59%11/3/2025 (Estimated)VANIVivani Medical-$23.49M-$0.45N/AN/AN/AN/A-194.66%-68.64%11/12/2025 (Estimated)Latest VANI, TCMD, SNWV, and BWAY EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails11/3/2025Q3 2025TCMDTactile Systems Technology$0.16N/AN/AN/A$79.31 millionN/A8/13/2025Q2 2025BWAYBrainsway$0.07$0.10+$0.03$0.10$12.34 million$12.63 million8/13/2025Q2 2025VANIVivani Medical-$0.10-$0.12-$0.02-$0.12N/AN/A8/8/2025Q2 2025SNWVSanuwave Health-$0.09$0.01+$0.10$0.01$10.14 million$10.16 million8/4/2025Q2 2025TCMDTactile Systems Technology$0.09$0.14+$0.05$0.14$73.93 million$78.91 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBWAYBrainswayN/AN/AN/AN/AN/ASNWVSanuwave HealthN/AN/AN/AN/AN/ATCMDTactile Systems TechnologyN/AN/AN/AN/AN/AVANIVivani MedicalN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBWAYBrainswayN/A3.513.34SNWVSanuwave HealthN/A0.430.31TCMDTactile Systems Technology0.113.793.36VANIVivani MedicalN/A1.301.30Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBWAYBrainsway30.11%SNWVSanuwave Health42.53%TCMDTactile Systems Technology83.43%VANIVivani Medical6.78%Insider OwnershipCompanyInsider OwnershipBWAYBrainsway19.00%SNWVSanuwave Health14.90%TCMDTactile Systems Technology2.50%VANIVivani Medical46.40%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBWAYBrainsway12018.97 million15.37 millionNot OptionableSNWVSanuwave Health408.57 million7.29 millionN/ATCMDTactile Systems Technology1,03722.29 million21.74 millionOptionableVANIVivani Medical2059.24 million31.76 millionOptionableVANI, TCMD, SNWV, and BWAY HeadlinesRecent News About These CompaniesVivani Medical withdraws record date for spin-off of CortigentOctober 4 at 6:45 AM | msn.comVivani Medical Withdraws Record Date for Spin Off of Cortigent SubsidiaryOctober 3, 2025 | marketwatch.comVivani Medical Withdraws Record Date for Cortigent Neuromodulation Subsidiary Spin-OffOctober 3, 2025 | globenewswire.comTanager Wealth Management LLP Sells 202,654 Shares of Vivani Medical, Inc. $VANIOctober 2, 2025 | marketbeat.comVivani Medical (NASDAQ:VANI) Trading Down 2.1% - Should You Sell?September 30, 2025 | marketbeat.comVivani Medical, Inc. to Participate in Emerging Growth Conference 86 on September 25, 2025September 24, 2025 | quiverquant.comQVivani Medical to Present at the Emerging Growth Conference on September 25, 2025September 24, 2025 | globenewswire.comVivani Medical Announces Spin-Off of CortigentSeptember 19, 2025 | msn.comVivani Medical (NASDAQ:VANI) Director Purchases $2,399,405.48 in StockSeptember 18, 2025 | marketbeat.comVivani Medical (NASDAQ:VANI) Director Gregg Williams Buys 2,068,453 SharesSeptember 18, 2025 | insidertrades.comVivani medical director Williams buys shares worth $2.4mSeptember 17, 2025 | investing.comVivani Medical Announces Record Date for Spin-off of Cortigent Neuromodulation Subsidiary to ShareholdersSeptember 17, 2025 | globenewswire.comVivani Medical Shares Insights at Industry ConferencesSeptember 9, 2025 | tipranks.comShort Interest in Vivani Medical, Inc. (NASDAQ:VANI) Drops By 32.5%September 9, 2025 | marketbeat.comSeptember 2025's Promising Penny Stock OpportunitiesSeptember 6, 2025 | finance.yahoo.comVivani Medical provides update on plans for NPM-139 semaglutide implantSeptember 4, 2025 | msn.comVivani Medical Provides Update on Clinical Development Plans for NPM-139 Semaglutide Implant for Chronic Weight ManagementSeptember 4, 2025 | globenewswire.comA brewing GLP-1 showdown, from Big Pharma pills to a biotech implantAugust 27, 2025 | finance.yahoo.comOzempic for dogs? I’d happily put my food-obsessed golden retriever on ‘Wagovy’August 24, 2025 | aol.comAAre weight-loss jabs for dogs the next big thing? Scientists exploring new solutions for pet obesityAugust 22, 2025 | msn.comOzempic For Pets: New Drug Being Tested For Animal Obesity - Here's What We KnowAugust 22, 2025 | msn.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeVANI, TCMD, SNWV, and BWAY Company DescriptionsBrainsway NASDAQ:BWAY$15.23 0.00 (0.00%) Closing price 04:00 PM EasternExtended Trading$15.23 0.00 (0.00%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson's diseases. The company serves doctors, hospitals, and medical centers in the field of psychiatry. BrainsWay Ltd. was founded in 2003 and is headquartered in Jerusalem, Israel.Sanuwave Health NASDAQ:SNWV$32.01 -8.81 (-21.58%) As of 04:00 PM EasternSANUWAVE Health, Inc., a shock wave technology company, researches, develops, and commercializes noninvasive, high-energy, and acoustic shock waves for regenerative medicine and other applications in the United States and internationally. Its shockwaves are used to produce a biological response resulting in the body healing itself through the repair and regeneration of tissue, and musculoskeletal and vascular structures. The company's lead regenerative product is the dermaPACE device for treating diabetic foot ulcers. Its portfolio of healthcare products and product candidates activate biologic signaling and angiogenic responses, including new vascularization and microcirculatory improvement, which helps to restore the body's normal healing processes and regeneration. The company also focuses on applying its Pulsed Acoustic Cellular Expression technology in wound healing, orthopedic, plastic/cosmetic, and cardiac conditions. In addition, it offers UltraMIST, non-contact and non-thermal ultrasound therapy device used to treat diabetic foot ulcers, pressure ulcers, venous leg ulcers, deep tissue pressure injuries, and surgical wounds; and orthoPACE system to treat tendinopathies and acute and nonunion fractures. The company was founded in 2005 and is headquartered in Suwanee, Georgia.Tactile Systems Technology NASDAQ:TCMD$14.84 -0.33 (-2.18%) Closing price 04:00 PM EasternExtended Trading$14.84 0.00 (0.00%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Tactile Systems Technology, Inc., a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema in the home setting; and Entre Plus System, a portable pneumatic compression device for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers. The company also provides Kylee, a mobile application to help patients learn about lymphedema, track their symptoms, and treatment, as well as to share their progress with their doctor; and AffloVest, a portable high frequency chest wall oscillation vest to treat patients with retained pulmonary secretions resulting from bronchiectasis, cystic fibrosis, and various neuromuscular disorders. Tactile Systems Technology, Inc. was incorporated in 1995 and is headquartered in Minneapolis, Minnesota.Vivani Medical NASDAQ:VANI$1.37 -0.04 (-2.84%) Closing price 04:00 PM EasternExtended Trading$1.37 0.00 (0.00%) As of 06:22 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Vivani Medical, Inc., a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need. It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals. The company is headquartered in Emeryville, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas AMD Could Double From Here—Thanks to Its Blockbuster OpenAI Deal EA’s $55 Billion Deal Spurs a Shake-Up in the Gaming Sector 3 Dividend Aristocrats to Buy Before Year’s End The Juice Is Loose: Why Plug Power's Rally Is Just the Beginning Joby's Stock Rallies as Public Flights Validate Global Game Plan SharkNinja Is Flashing a Buy Signal the Market Is Ignoring Why Semtech Stock Is Rallying After Its NVIDIA Setback Marvell Insiders Buy Shares—Should Investors Follow Suit? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
